超声造影:独具慧眼“看”肿瘤生物治疗——savetime,savelife(珍惜时间,拯救生命)
摘要
半个世纪以来，综合治疗已成为肿瘤治疗的最佳模式，尤其是免疫学和分子细胞生物学的发展，使得我们对肿瘤形成过程中的受体、基因和信号转导有了更深入地了解，在此基础上发展的生物治疗也因此成为21世纪肿瘤治疗的主要方向和潮流，在多种肿瘤的治疗方法中取得了显著进展。
出处
《中国医疗设备》
2008年第9期160-161,共2页
China Medical Devices
参考文献10
-
1Ray-Coquard I,,Le CA,Michallet V,et al.Gastrointestinalstromal tumors:news and comments[].Bulletin du Cancer.2003
-
2Lassau N,Lamuraglia M,Vanel D,et al.Doppler US withperfusion software and contrast medium injection in the ear-ly evaluation of isolated limb perfusion of limb sarcomas:prospective study of 49 cases[].Annals of Oncology.2005
-
3Nathalie Lassau,Michele Lamuraglia,Linda Chami,et al.Gas-trointestinal stromal tumors treated with imatinib:monitoringresponse with contrast-enhanced sonography[].American Journal of Roentgenology.2006
-
4Cioni D,R Lencioni,S Rossi,et al.Radiofrequency thermalablation of hepatocellular carcinoma:using contrast-enhancedharmonic power Doppler sonography to assess treatmentoutcome[].American Journal of Roentgenology.2001
-
5Cova L,L Solbiati,T Lerace,et al.Usefulness of contrast-en-hanced ultrasonography and real-time low mechanical indexharmonic imaging in the selection and monitoring of patientsenundergoing percutaneous radiofrequency thermal ablationof liver tumors[].European Radiology.2003
-
6Michele Lamuraglia,Bernard Escudier,Linda Chami,et al.Topredict progression-free survival and overall survival inmetastatic renal cancer treated with sorafenib:Pilot study us-ing dynamic contrast-enhanced Doppler ultrasound[].EJC.2006
-
7Hsu C,Chen CN,Chen LT,et al.Effect of thalidomide inhepatocellular carcinoma:assessment with power doppler USand analysis of circulating angiogenic factors[].Radiology.2005
-
8Lassau N,Koscielny S,Opolon P,De Baere T,Peronneau P,Leclere J,Roche A.Evaluation of contrast -enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo[].Investigative Radiology.2001
-
9De Baere T,Bessoud B,Dromain C,et al.Radiofrequency ablation of 1 0 0 hepatic metastases with a mean follow-up of more than 1 year[].American Journal of Roentgenology.2000
-
10Escudier B,Lassau N,Couanet D,et al.Phase II trial of thalidomide in renal cell carcinoma[].Annals of Oncology.2002
-
1瞿全新,赵凤喜.卵巢癌转移机制的分子细胞生物学研究进展[J].国外医学（妇产科学分册）,1996,23(6):351-354. 被引量：1
-
2M.von Knebel Doeberitz,Christinavon Knebel Doeberitz,张林.分子细胞生物学——外科肿瘤学诊断治疗新方法的基础[J].德国医学,1999,16(5):249-252.
-
3B.M.Ghadimi,P.m.Schlag,武忠弼.肿瘤转移的分子基础及治疗选择[J].德国医学,1999,16(5):254-258.
-
4梁荣祥,李苏萌.恶性肿瘤的分子靶向治疗[J].山东医药,2010,50(1):104-105. 被引量：7
-
5张子瑾,程刚.分子靶向药物治疗非小细胞肺癌的临床研究进展[J].中国新药杂志,2005,14(10):1141-1145. 被引量：10
-
6周航（综述）,梅同华,赵麟丰（审校）.肺癌分子靶向治疗的现状与进展[J].国际肿瘤学杂志,2007,34(7):493-496. 被引量：1
-
7梁寒.复发转移胃肠间质瘤的治疗策略[J].腹部外科,2013(6):369-370. 被引量：2
-
8刘军,任秀宝,郝希山,庞青松.食管小细胞癌不同模式的综合治疗生存分析[J].中国肿瘤临床,2012,29(22):1814-1817. 被引量：3
-
9陈立权,丁士海,庞士勇,费维国.17例男性乳腺癌临床分析[J].深圳中西医结合杂志,2014,24(10):86-87.
-
10王玉,陈子江.比较基因组杂交的研究进展[J].国际生殖健康／计划生育杂志,2008,27(1):14-17. 被引量：2
